Theory-wise it is quite credible as underarm antiperspirants or deodorants are applied to the skin very close to the breast.
In the past two decades, doctors have noted a significant increase in the incidence of breast cancer among younger women.
“The new price of the drug being marketed under the brand name ‘Trumab’, will be Rs 15,749 per 440 mg…
The Indian Council of Medical Research (ICMR) along with the National Cancer Registry Programme (NCRP) in its report last year…
In addition to its breast cancer screening services, Vara also conducts awareness campaigns to educate women about breast cancer and…
According to BDR Pharma, in India having a generic version of Palbociclib mean that many patients of (HR+) (HER2-) advanced…
Ramiven is already approved for the treatment of certain types of HR+ HER2- advanced or metastatic breast cancer.
Breast cancer is the leading cause of cancer in women in India and its risk increases with age. It is…
The company claims that the safety profile of capivasertib plus Faslodex was similar to that observed in previous trials evaluating…
The company claims that Camizestrant was well tolerated, and its safety profile was consistent with that observed in previous trials…
Breast reconstruction surgery can significantly boost self-esteem and have a positive effect on the mental health and social life of…
According to statistics, every 4 minutes, a woman is diagnosed with breast cancer – the most common cancer occurring among…
Typically, the cancer forms in either the lobules or the ducts of the breast. Lobules are the glands that produce…
The decade-long study was conducted in a randomised manner by investigators at 11 cancer centres in India including Tata Memorial…
The U.S. Food and Drug Administration (USFDA) on Thursday said that it has received several reports of certain types of…
The pharma major claims that Kisqali is the only CDK4/6 inhibitor with proven overall survival benefit across all its three…
According to the company’s press statement, the approval was based on results from the OlympiA Phase III trial, which suggested…
A trial dubbed AMEERA-5, which was testing amcenestrant on women with newly diagnosed advanced breast cancer, was stopped early because…